-- 根据周四提交给香港交易所的文件显示，InSilico Medicine（港交所代码：3696）投资了1.05亿美元，用于投资招商国际和摩根大通提供的财富管理产品。 这家人工智能驱动的药物研发公司将其中5000万美元投资于招商国际资产管理公司管理的货币市场基金，预期年化收益率为3.99%；5000万美元投资于摩根大通资产管理公司管理的可变净值货币市场基金，预期年化收益率为3.85%；另有500万美元投资于摩根大通银行发行的双币种存款，预期收益率为4.68%。 该公司表示，此次认购旨在“提高盈余现金的收益”。
Related Articles
Asia
Fudan-Zhangjiang Bio-Pharma's Profit Jumps 189% in Q1
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349, SHA:688505) posted net profit attributable to shareholders of 7.7 million yuan for the first quarter, up 189% from 2.7 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Hong Kong-listed shares of the biotech firm were up nearly 2% in recent trade.Earnings per share came in at 0.01 yuan, compared with a near-zero figure a year earlier.Revenue fell 17% to 149.1 million yuan from 179.9 million yuan in the prior-year period.
$HKG:1349$SHA:688505
Asia
Coliwoo Forecasts Higher Net Profit in Fiscal H1
Coliwoo (SGX:W8W) is expecting to book a higher net profit before tax for the fiscal first half ended March 31, according to a Wednesday filing with the Singapore Exchange.The co-living provider has attributed this to net fair value gains on its investment properties during the period.
$SGX:W8W
Asia
Hot Chili Plans to Accelerate Drilling Across Chile Copper-Gold Porphyry Discovery
Hot Chili (ASX:HCH) plans to accelerate drilling across the La Verde copper-gold porphyry discovery in Chile to establish a maiden mineral resource and further define the potential size, scale, and grade of a higher-grade starter pit for the Costa Fuego project, also in Chile, according to a Thursday Australian bourse filing.The company said it plans to complete and submit an environmental impact assessment for Costa Fuego and start a feasibility study for the project.Hot Chili intends to integrate La Verde into an expanded mine plan.
$ASX:HCH